Track topics on Twitter Track topics that are important to you
Min Wang has been appointed chief legal and administrative officer of Cambridge, MA-based BlueRock Therapeutics. Wang was most recently general counsel and corporate secretary of Agios Pharmaceuticals (NASDAQ: AGIO). Her experience also includes posts at Genentech and Merck (NYSE: MRK). BlueRock, which develops regenerative medicines for tough-to-treat diseases, launched in late 2016 backed by $225 […]
Original Article: BlueRock Therapeutics Adds Min Wang to C-SuiteNEXT ARTICLE
Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...